Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their waistlines.
www.bloomberg.com
#Novo #Nordisk #Lost #Lead #WeightLoss #Market
Caterpillar is warning investors it now expects tariffs to have an even greater impact on its business, costing it as…
Growing numbers of emerging-market companies are borrowing overseas at cheaper rates than their countries of origin, a sign that sovereign…
The Australian government plans to establish a regulator to improve compliance and enforcement of environmental laws as part of proposed…
